Healx
Healx is an AI-native pharmaceutical company that uses artificial intelligence to develop new treatments for rare diseases.
Healx has raised €105M across 4 funding rounds from 5 investors, most recently a round in Aug 2024. Based in Milton, UK; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€105M
€104,832,833
Funding rounds
4
Investors
5
distinct backers
Active since
2016-10
latest 2024-08
Funding by year
EUR raised per yearHealx — funding by year — interactive chart.
Data table
| Healx — funding by year | |
|---|---|
| 2016 | €1.3M |
| 2018 | €8.5M |
| 2019 | €51M |
| 2024 | €44M |
Signals
High confidenceRaise-next likelihood15
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood13
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 4 rounds raised
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-08-01 | Other | €44M | Atomico,R42 Group | View deal → |
| 2019-10-01 | Series B | €51M | Atomico | View deal → |
| 2018-07-18 | Series A | €8.5M | Amadeus Capital Partners,Balderton Capital | View deal → |
| 2016-10-01 | Series A | €1.3M | Amadeus Capital Partners | View deal → |